| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 315.03 KB | Adobe PDF |
Orientador(es)
Resumo(s)
This paper examines the incentive to adopt a new technology given by
some popular reimbursement systems, namely cost reimbursement and DRG
reimbursement. Adoption is based on a cost-benefit criterion. We find that
retrospective payment systems require a large enough patient benefit to yield
adoption, while under DRG, adoption may arise in the absence of patients
benefits when the differential reimbursement for the old vs. new technology
is large enough. Also, cost reimbursement leads to higher adoption under
some conditions on the differential reimbursement levels and patient benefits.
In policy terms, cost reimbursement system may be more effective than
a DRG payment system. This gives a new dimension to the discussion of
prospective vs. retrospective payment systems of the last decades centered
on the debate of quality vs. cost containment.
Descrição
Palavras-chave
health technology payment system
